Comparative Analysis of Intravenous Pumps Relocation for Critically Ill Isolated COVID-19 Patients From Bedside to Outside the Patient Room
OBJECTIVES: To quantify the impact of IV pump relocation for COVID-19 patients from the bedside to outside the patient room on nurse exposure to COVID-19 and conservation of PPE.
DESIGN: Original Article.
SETTING: Intensive care units at a single-center teaching hospital.
PATIENTS: Critically ill COVID-19 patients under contact and special droplet precautions.
INTERVENTIONS: Relocation of intravenous pumps for COVID-19 patients from bedside to outside the patient room using extension tubing.
MEASUREMENTS AND MAIN RESULTS: The primary objective of the study was to measure the impact of this strategy on COVID-19 exposure, utilizing the number of nurse entries into the patient room as a surrogate endpoint, and extrapolation of this data to determine the reduction or PPE usage. Secondary endpoints included incidence of extravasation, hyperglycemia, hypotension, and diagnosis of CLABSI/bacteremia. A statistically significant reduction in the primary endpoint of the study was observed as room entries prior to pump relocation averaged 15.36 (± 4.10) as opposed to an average of 7.92 (± 2.19) following pump relocation (p < 0.0001). In both pre- and post-pump relocation groups, there was no incidence of extravasation or CLABSI. No significant differences were noted in number of patients experiencing hyperglycemia, hypotensive episodes, or bacteremia.
CONCLUSIONS: There was a significant decrease in COVID-19 exposure based on the number of nurse entries following the relocation of intravenous pumps from inside to outside of the patient room. These results may be cautiously extrapolated to suggest a decrease in personal protective equipment utilization. Future prospective, randomized controlled trials investigating the impact of this strategy are required.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
---|---|
Enthalten in: |
Journal of intensive care medicine - 36(2021), 6 vom: 02. Juni, Seite 719-725 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shah, Ami [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 28.05.2021 Date Revised 23.04.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1177/0885066621989920 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320917304 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320917304 | ||
003 | DE-627 | ||
005 | 20231225174712.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/0885066621989920 |2 doi | |
028 | 5 | 2 | |a pubmed24n1069.xml |
035 | |a (DE-627)NLM320917304 | ||
035 | |a (NLM)33530822 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Shah, Ami |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparative Analysis of Intravenous Pumps Relocation for Critically Ill Isolated COVID-19 Patients From Bedside to Outside the Patient Room |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.05.2021 | ||
500 | |a Date Revised 23.04.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVES: To quantify the impact of IV pump relocation for COVID-19 patients from the bedside to outside the patient room on nurse exposure to COVID-19 and conservation of PPE | ||
520 | |a DESIGN: Original Article | ||
520 | |a SETTING: Intensive care units at a single-center teaching hospital | ||
520 | |a PATIENTS: Critically ill COVID-19 patients under contact and special droplet precautions | ||
520 | |a INTERVENTIONS: Relocation of intravenous pumps for COVID-19 patients from bedside to outside the patient room using extension tubing | ||
520 | |a MEASUREMENTS AND MAIN RESULTS: The primary objective of the study was to measure the impact of this strategy on COVID-19 exposure, utilizing the number of nurse entries into the patient room as a surrogate endpoint, and extrapolation of this data to determine the reduction or PPE usage. Secondary endpoints included incidence of extravasation, hyperglycemia, hypotension, and diagnosis of CLABSI/bacteremia. A statistically significant reduction in the primary endpoint of the study was observed as room entries prior to pump relocation averaged 15.36 (± 4.10) as opposed to an average of 7.92 (± 2.19) following pump relocation (p < 0.0001). In both pre- and post-pump relocation groups, there was no incidence of extravasation or CLABSI. No significant differences were noted in number of patients experiencing hyperglycemia, hypotensive episodes, or bacteremia | ||
520 | |a CONCLUSIONS: There was a significant decrease in COVID-19 exposure based on the number of nurse entries following the relocation of intravenous pumps from inside to outside of the patient room. These results may be cautiously extrapolated to suggest a decrease in personal protective equipment utilization. Future prospective, randomized controlled trials investigating the impact of this strategy are required | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Observational Study | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a coronavirus | |
650 | 4 | |a infusion pumps | |
650 | 4 | |a personal protective equipment (PPE) | |
650 | 4 | |a relocation | |
700 | 1 | |a Xu, Jiashan |e verfasserin |4 aut | |
700 | 1 | |a Friedman, Seana |e verfasserin |4 aut | |
700 | 1 | |a Puskas, John D |e verfasserin |4 aut | |
700 | 1 | |a Bhatt, Himani V |e verfasserin |4 aut | |
700 | 1 | |a Yimen, Mekeleya |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of intensive care medicine |d 1991 |g 36(2021), 6 vom: 02. Juni, Seite 719-725 |w (DE-627)NLM08584439X |x 1525-1489 |7 nnns |
773 | 1 | 8 | |g volume:36 |g year:2021 |g number:6 |g day:02 |g month:06 |g pages:719-725 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/0885066621989920 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 36 |j 2021 |e 6 |b 02 |c 06 |h 719-725 |